12345...Last
Methodology Test Name Test Description Results per page:
IHC Acute Leukemia IHC Panel

Staining with the following antibodies to identify acute leukemia in bone marrow clots and core biopsies: CD3, CD7, CD20, CD34, CD45 LCA, CD56, CD117, MPO, PAX-5, and TdT.

This panel is available on a tech-only basis. For global testing, please order a consult so our pathologists may select the best combination of stains for your case. 

IHC Adenocarcinoma vs. Mesothelioma IHC Panel Staining with the following seven antibodies to differentiate pulmonary adenocarcinoma from malignant mesothelioma, epithelial type: Pan-Cytokeratin Plus, CEA, MOC-31, BerEP4, TTF1, calretinin, and WT-1.

This panel is available on a tech-only basis. For global testing, please order a consult so our pathologists may select the best combination of stains for your case.

FISH AML Extended Panel (non-NY)
  • Disease(s):
    • Acute myeloid leukemia
  • Probes:
    • RPN1, MECOM (3q21, 3q26.2)
    • 5q-, -5 (5p15, 5q31, 5q33)
    • 7q-, -7 (7q31, Cen 7)
    • Trisomy 8 (Cen 8)
    • DEK/CAN t(6;9)
    • MLL (11q23)
    • ETV6 (12p13)
    • 17p- (TP53 17p13.1, Cen 17 dual-color)
    • Probes may be ordered separately.
FISH AML Favorable-Risk Panel
  • Disease(s):
    • Acute myeloid leukemia
  • Probes:
    • RUNX1/RUNX1T1 (ETO/AML1) t(8;21)
    • PML/RARA t(15;17)
    • CBFB inv(16), t(16;16)
    • Probes may be ordered separately.
FISH AML Standard Panel (non-New York)
  • Disease(s):  Acute myeloid leukemia
  • Probes
    • 5q-, -5  (5p15, 5q31, 5q33)
    • 7q-, -7  (7q31, Cen 7) 
    • Trisomy 8  (Cen 8) 
    • MLL (11q23)
    • 20q- (20q12, 20qter)
    • RUNX1/RUNX1T1 (ETO/AML1) t(8;21) 
    • PML/RARA t(15;17) 
    • CBFB inv(16), t(16;16)
    • Probes may be ordered separately except +8 and 20q- which are combined.  
FISH AML FISH Panel (New York)
  • Disease(s): AML
  • Probes:
    • 5q-, -5 (5p15.2, 5q33-34)
    • 7q-, -7 (7q31, Cen 7)
    • Trisomy 8 (Cen 8)
    • MLL (11q23)
    • RUNX1T1/RUNX1 (ETO/AML1) t(8;21)
    • PML/RARA t(15;17)
    • CBFB inv(16), t(16;16)
    • Probes may be ordered separately.
IHC B-Cell Lymphoma Panel Staining with the following 12 antibodies for diagnosis, grading, and determining the prognosis of various subtypes of B-cell lymphoma: BCL-1, BCL-2, BCL-6, CD3, CD5, CD10, CD20, CD23, CD30, Ki-67, MUM1, PAX-5.

This panel is available on a tech-only basis. For global testing, please order a consult so our pathologists may select the best combination of stains for your case.

IHC Bladder vs. Prostate Carcinoma IHC Panel Staining with the following antibodies to differentiate bladder from prostate cancer: Pan-Cytokeratin Plus (AE1/AE3 + CK 8/18), CK 7, CK 20, PSAP, and PIN-4.

This panel is available on a tech-only basis. For global testing, please order a consult so our pathologists may select the best combination of stains for your case.

IHC Breast IHC Panel

Staining with the following four or five antibodies, according to the client’s instruction, to characterize breast tumors for therapeutic planning: ER, PgR, HER2, Ki-67, with or without p53. Reflex to HER2 FISH after HER2 IHC is available.

This panel is available on a global or tech-only basis.

IHC Burkitt vs. DLBC Lymphoma IHC Panel Staining with the following antibodies to distinguish Burkitt, DLBCL, and double-hit lymphoma: BCL-2, c-MYC, Ki-67. FISH testing for MYC rearrangements may be useful in the work-up of this differential diagnosis.

This panel is available on a tech-only basis. For global testing, please order a consult so our pathologists may select the best combination of stains for your case.

12345...Last